85349-9
Lymph node response to neoadjuvant therapy in Cancer specimen by CAP cancer protocols
Active
Term Description
The response of the tumor to neoadjuvant treatment, such as chemotherapy, radiation therapy, or endocrine therapy.
LOINC Names Get Info
- Fully-Specified Name
- Lymph node response to neoadjuvant therapy:
Find: Pt: Cancer specimen: Nom: CAP cancer protocols - Long Common Name
- Lymph node response to neoadjuvant therapy in Cancer specimen by CAP cancer protocols
- Short Name
- LN resp neoadj therapy Ca spec CAP prot
- Display Name
- Lymph node response to neoadjuvant therapy CAP Nom (Cancer specimen)
- Consumer Name Alpha Get Info
- Lymph node response to neoadjuvant therapy, Cancer specimen
Part Model Get Info
- Component
- Lymph node response to neoadjuvant therapy
LP247952-7
- Analyte
- Lymph node response to neoadjuvant therapy
LP247952-7
- Component Numerator
- Lymph node response to neoadjuvant therapy
LP247952-7
- Component Numerator Core
- Lymph node response to neoadjuvant therapy
LP247952-7
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Find
LP6813-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Cancer specimen
LP247830-5
- System Core
- Cancer specimen
LP247830-5
- Super System
- NULL
- Scale
- Nom
LP7750-5
- Method
- CAP cancer protocols
LP32200-5
Normative Answer List: LL4387-8
Source: College of American Pathologists| Answer | Code | Score | Answer ID |
|---|---|---|---|
| No known presurgical therapy | LA27236-1 | ||
| No lymph nodes removed | LA27241-1 | ||
| No definitive response to presurgical therapy in metastatic carcinoma | LA27242-9 | ||
| Probable or definite response to presurgical therapy in metastatic carcinoma | LA27243-7 | ||
| No lymph node metastases. Fibrous scarring, possibly related to prior lymph node metastases with pathologic complete response | LA27244-5 | ||
| No lymph node metastases and no prominent fibrous scarring in the nodes | LA27245-2 |
Basic Attributes
- Class
- PATH
- Type
- Laboratory
- First Released
- Version 2.61
- Last Updated
- Version 2.61 (ADD)
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 85904-1 | Cancer pathology panel - Breast cancer specimen by CAP cancer protocols |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Uzlina lymfatická odpověď na neoadjuvantní terapii: |
| el-GR | Greek (Greece) | Ανταπόκριση των λεμφαδένων στη νεοεπικουρική θεραπεία: Synonyms: Nom PATH Pt Ανταπόκριση στη νεοεπικουρική θεραπεία Ανταπόκριση των λεμφαδένων στη νεοεπικουρική θεραπεία Δείγμα Δείγμα καρκίνου Εύρεση Καρκίνος Πρωτόκολλα CAP για τον καρκίνο |
| es-ES | Spanish (Spain) | respuesta del ganglio linfatic a terapia neoadyuvante: |
| es-MX | Spanish (Mexico) | Respuesta de los ganglios linfáticos a la terapia neoadyuvante: |
| it-IT | Italian (Italy) | Risposta di linfonodo a terapia neoadiuvante: Synonyms: Campione di tumore Coinvolgimento del linfonodo Neoplasia maligna Osservazione Patologia Protocolli neoplasia maligna CAP Punto nel tempo (episodio) |
| zh-CN | Chinese (China) | 淋巴结对于新辅助疗法的反应: Synonyms: CAP 癌症方案; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Copyright
- Organization
- College of American Pathologists
- Copyright
- Copyright © 2017 College of American Pathologists
- Terms of Use
- Used with permission
- URL
- https://www.cap.org/
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://